Ceros Capital Markets
Overview
Ceros Capital Markets is the venture capital and investment banking arm of Ceros Financial Services. It specializes in fundraising (primarily Series A-D) and direct investments for companies in the MedTech, medical device, robotics, biotech, and digital health sectors. The firm acts as a placement agent and its parent company is a registered broker-dealer.
Portfolio Companies
4
Website
ceroscapitalmarkets.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DermaSensor, Inc. | Jun 2022 | Series A Extension | Lead |
| TriFlo Cardiovascular Inc. | Jun 2022 | Series A | Co-investor |
| Pristine Surgical | Mar 2022 | Series D | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ceros Capital Markets based?
Ceros Capital Markets is headquartered in Miami, Florida, United States.
When was Ceros Capital Markets founded?
Founding year information for Ceros Capital Markets is not publicly available.
How many portfolio companies does Ceros Capital Markets have?
Ceros Capital Markets has 4 portfolio companies in Caplight's dataset.
What are some companies in Ceros Capital Markets's portfolio?
Portfolio companies visible on Caplight include DermaSensor, Inc., TriFlo Cardiovascular Inc., Pristine Surgical.
What was Ceros Capital Markets's most recent investment shown here?
Ceros Capital Markets's most recent investment in this portfolio sample was in TriFlo Cardiovascular Inc. in 2022.
What sectors does Ceros Capital Markets focus on?
Ceros Capital Markets focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Ceros Capital Markets focus on?
Ceros Capital Markets typically invests at the Mid stage.